This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2000-2001.
Company Filing History:
1 out of 1,217 
1 out of 3,690 
Years Active: 2000-2001
Title: Fredric E Wondisford: Innovator in Synthetic Thyrotropin
Introduction
Fredric E Wondisford is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic thyrotropin. With a total of 2 patents, his work has paved the way for advancements in diagnostic and therapeutic applications.
Latest Patents
Wondisford's latest patents include the creation of biologically active synthetic thyrotropin and a cloned gene for producing the same. Substantially pure recombinant TSH has been prepared from a clone comprising the complete nucleotide sequence for the expression of TSH. The diagnostic and therapeutic applications of synthetic TSH are thoroughly described in his patents.
Career Highlights
Throughout his career, Wondisford has worked with esteemed organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the United States of America as represented by the Department of Health. His innovative work has had a lasting impact on the field of health and medicine.
Collaborations
Wondisford has collaborated with notable professionals in his field, including Bruce D Weintraub. Their joint efforts have contributed to the advancement of research and development in biotechnology.
Conclusion
Fredric E Wondisford's contributions to the field of synthetic thyrotropin exemplify the importance of innovation in biotechnology. His patents and collaborations highlight the potential for advancements in medical diagnostics and therapies.